Kun‐Hung Shen

1.4k total citations
35 papers, 1.1k citations indexed

About

Kun‐Hung Shen is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Kun‐Hung Shen has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Surgery and 6 papers in Oncology. Recurrent topics in Kun‐Hung Shen's work include Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (7 papers) and Peptidase Inhibition and Analysis (3 papers). Kun‐Hung Shen is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (7 papers) and Peptidase Inhibition and Analysis (3 papers). Kun‐Hung Shen collaborates with scholars based in Taiwan and United States. Kun‐Hung Shen's co-authors include Yuan‐Wei Shih, Shun‐Hsing Hung, Po‐Lin Kuo, Ya‐Ling Hsu, Chi‐Sheng Chien, Shian-Chin Ko, Jau‐Shyang Huang, Chien‐Feng Li, Changliang Liu and Cheng‐Hsun Wu and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Kun‐Hung Shen

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kun‐Hung Shen Taiwan 19 531 209 195 171 166 35 1.1k
A‐Mei Huang Taiwan 23 735 1.4× 232 1.1× 194 1.0× 97 0.6× 78 0.5× 51 1.2k
Chuan‐Ming Xie China 18 738 1.4× 187 0.9× 185 0.9× 176 1.0× 90 0.5× 42 1.3k
Zhi Dai China 20 975 1.8× 241 1.2× 370 1.9× 170 1.0× 189 1.1× 59 1.9k
Mohammad R. Salabat United States 13 516 1.0× 258 1.2× 217 1.1× 274 1.6× 89 0.5× 24 1.1k
Sung Yong Kim South Korea 15 487 0.9× 322 1.5× 193 1.0× 117 0.7× 86 0.5× 75 1.2k
Sen Lian South Korea 19 491 0.9× 149 0.7× 183 0.9× 125 0.7× 76 0.5× 28 928
Shuwen Yu China 18 670 1.3× 218 1.0× 186 1.0× 132 0.8× 83 0.5× 49 1.4k
Young‐Chae Chang South Korea 16 527 1.0× 117 0.6× 159 0.8× 146 0.9× 84 0.5× 29 1.1k
Eswar Shankar United States 24 799 1.5× 190 0.9× 292 1.5× 154 0.9× 115 0.7× 50 1.4k
Sin‐Aye Park South Korea 20 719 1.4× 208 1.0× 229 1.2× 89 0.5× 114 0.7× 44 1.1k

Countries citing papers authored by Kun‐Hung Shen

Since Specialization
Citations

This map shows the geographic impact of Kun‐Hung Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun‐Hung Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun‐Hung Shen more than expected).

Fields of papers citing papers by Kun‐Hung Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun‐Hung Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun‐Hung Shen. The network helps show where Kun‐Hung Shen may publish in the future.

Co-authorship network of co-authors of Kun‐Hung Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Kun‐Hung Shen. A scholar is included among the top collaborators of Kun‐Hung Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun‐Hung Shen. Kun‐Hung Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shen, Kun‐Hung, Jui‐Hsiang Hung, Chia‐Wei Chang, et al.. (2017). Solasodine inhibits invasion of human lung cancer cell through downregulation of miR-21 and MMPs expression. Chemico-Biological Interactions. 268. 129–135. 72 indexed citations
3.
Yü, Dah‐Shyong, et al.. (2015). Bacille Calmette‐Guerin can induce cellular apoptosis of urothelial cancer directly through toll‐like receptor 7 activation. The Kaohsiung Journal of Medical Sciences. 31(8). 391–397. 36 indexed citations
4.
Kuo, Po‐Lin, Kun‐Hung Shen, Shun‐Hsing Hung, & Ya‐Ling Hsu. (2012). CXCL1/GROα increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-κB/HDAC1 epigenetic regulation. Carcinogenesis. 33(12). 2477–2487. 89 indexed citations
5.
Shen, Kun‐Hung, et al.. (2012). Epigenetic regulation of vascular endothelial growth factor a dynamic expression in transitional cell carcinoma. Molecular Carcinogenesis. 52(7). 568–579. 10 indexed citations
6.
Liang, Peir‐In, Li-Ching Wu, Jim Jinn‐Chyuan Sheu, et al.. (2012). Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma. Journal of Clinical Pathology. 65(9). 802–807. 12 indexed citations
7.
Shen, Kun‐Hung, Zong‐Tsi Chen, & Pin‐Der Duh. (2012). Cytotoxic Effect of Eucalyptus citriodora Resin on Human Hepatoma HepG2 Cells. The American Journal of Chinese Medicine. 40(2). 399–413. 28 indexed citations
8.
Huan, Steven K., et al.. (2011). A multivariable logistic regression equation to evaluate prostate cancer. Journal of the Formosan Medical Association. 110(11). 695–700. 3 indexed citations
10.
Shen, Kun‐Hung, et al.. (2011). Effects of Electroacupuncture on Benign Prostate Hyperplasia Patients with Lower Urinary Tract Symptoms: A Single‐Blinded, Randomized Controlled Trial. Evidence-based Complementary and Alternative Medicine. 2011(1). 303198–303198. 15 indexed citations
11.
Shen, Kun‐Hung, En‐Shyh Lin, Po‐Lin Kuo, Chung‐Yi Chen, & Ya‐Ling Hsu. (2011). Isolinderanolide B, a Butanolide Extracted From the Stems of Cinnamomum subavenium, Inhibits Proliferation of T24 Human Bladder Cancer Cells by Blocking Cell Cycle Progression and Inducing Apoptosis. Integrative Cancer Therapies. 10(4). 350–358. 12 indexed citations
13.
Shen, Kun‐Hung, et al.. (2009). Determining urinary trace elements (Cu, Zn, Pb, As, and Se) in patients with bladder cancer. Journal of Clinical Laboratory Analysis. 23(3). 192–195. 23 indexed citations
14.
Shen, Kun‐Hung, et al.. (2009). Acacetin, a flavonoid, inhibits the invasion and migration of human prostate cancer DU145 cells via inactivation of the p38 MAPK signaling pathway. Molecular and Cellular Biochemistry. 333(1-2). 279–291. 99 indexed citations
16.
Chien, Chi‐Sheng, Kun‐Hung Shen, Jau‐Shyang Huang, Shian-Chin Ko, & Yuan‐Wei Shih. (2009). Antimetastatic potential of fisetin involves inactivation of the PI3K/Akt and JNK signaling pathways with downregulation of MMP-2/9 expressions in prostate cancer PC-3 cells. Molecular and Cellular Biochemistry. 333(1-2). 169–180. 122 indexed citations
17.
Hung, Shun‐Hsing, Kun‐Hung Shen, Cheng‐Hsun Wu, Changliang Liu, & Yuan‐Wei Shih. (2009). α-Mangostin Suppresses PC-3 Human Prostate Carcinoma Cell Metastasis by Inhibiting Matrix Metalloproteinase-2/9 and Urokinase-Plasminogen Expression through the JNK Signaling Pathway. Journal of Agricultural and Food Chemistry. 57(4). 1291–1298. 98 indexed citations
18.
Shen, Kun‐Hung, et al.. (2008). PREMARIN CAN ACT VIA ESTROGEN RECEPTORS TO RESCUE MICE FROM HEATSTROKE-INDUCED LETHALITY. Shock. 30(6). 668–674. 30 indexed citations
19.
Shen, Kun‐Hung, Jiunn‐Kae Chang, Ya‐Ling Hsu, & Po‐Lin Kuo. (2007). Chalcone Arrests Cell Cycle Progression and Induces Apoptosis through Induction of Mitochondrial Pathway and Inhibition of Nuclear Factor Kappa B Signalling in Human Bladder Cancer Cells. Basic & Clinical Pharmacology & Toxicology. 101(4). 254–261. 75 indexed citations
20.
Hsueh, Thomas Y., et al.. (2004). A comparison of the clinical outcome between open and hand‐assisted laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma. British Journal of Urology. 94(6). 798–801. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026